ResearcherUniversitat Pompeu FabraNo recent work listed

Luciano Sobrevals

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5068667427. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: 1 paper

Papers 2

AduPARE1A and gemcitabine combined treatment trigger synergistic antitumor effects in pancreatic cancer through NF-κB mediated uPAR activation. Co-author DOI 10.1186/s12943-015-0413-2 ↗
Pancreatic cancer gene therapy: from molecular targets to delivery systems. Last author DOI 10.3390/cancers3010368 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

María Victoria Maliandi · 2 shared papers, 2011–2015 · strength 0.09
- Paper AduPARE1A and gemcitabine combined treatment trigger synergistic antitumor effects in pancreatic cancer through NF-κB m… DOI 10.1186/s12943-015-0413-2 ↗
- Paper Pancreatic cancer gene therapy: from molecular targets to delivery systems. DOI 10.3390/cancers3010368 ↗
Cristina Fillat · 2 shared papers, 2011–2015 · strength 0.09
- Paper AduPARE1A and gemcitabine combined treatment trigger synergistic antitumor effects in pancreatic cancer through NF-κB m… DOI 10.1186/s12943-015-0413-2 ↗
- Paper Pancreatic cancer gene therapy: from molecular targets to delivery systems. DOI 10.3390/cancers3010368 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.